Answers are grounded in this paper and cite their sources.
Case report reveals diffuse large B-cell lymphoma in a patient with long-term remission of ulcerative colitis, suggesting the need for vigilance during monitoring.
Malignant lymphoma in ulcerative colitis (UC) is uncommon, and diffuse large B-cell lymphoma (DLBCL) without immunosuppressive or biologic therapy is particularly rare. We report a case of an Epstein-Barr virus-negative patient with long-standing left-sided UC in remission who developed rapidly enlarging synchronous DLBCL lesions in the ascending and sigmoid colon. The diagnosis was made endoscopically and histologically, and treatment with Pola-R-CHP followed by rituximab achieved a complete remission. A literature review showed that most UC-associated lymphomas are EBV-positive DLBCL related to immunosuppression. Although malignant lymphoma is rare in patients with UC, it can occur and therefore should be considered during surveillance colonoscopy.
No takes yet. Share an insight, caveat, or question.
Kikukawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: